Ann-christin Gnirck
Hamburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Pathology-oriented multiplexing enables integrative disease mapping.
Journal: Nature
Published: November 13, 2023
Retinoic acid drives intestine-specific adaptation of effector ILC2s originating from distant sites.
Retinoic acid drives intestine-specific adaptation of effector ILC2s originating from distant sites.
Journal: The Journal of experimental medicine
Published: June 13, 2022
Mucosal-associated invariant T cells contribute to suppression of inflammatory myeloid cells in immune-mediated kidney disease.
Journal: Nature communications
Published: March 25, 2022
Conventional NK Cells and Type 1 Innate Lymphoid Cells Do Not Influence Pathogenesis of Experimental Glomerulonephritis.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: October 21, 2021
Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients.
Journal: Science immunology
Published: November 13, 2020
Innate Lymphoid Cells in Renal Inflammation.
Journal: Frontiers in immunology
Published: November 21, 2019
IL22BP Mediates the Antitumor Effects of Lymphotoxin Against Colorectal Tumors in Mice and Humans.
Journal: Gastroenterology
Published: September 20, 2019
Endogenous IL-22 is dispensable for experimental glomerulonephritis.
Journal: American journal of physiology. Renal physiology
Published: February 07, 2019
T cell-derived IFN-γ downregulates protective group 2 innate lymphoid cells in murine lupus erythematosus.
Journal: European journal of immunology
Published: August 29, 2017
IL-33-Mediated Expansion of Type 2 Innate Lymphoid Cells Protects from Progressive Glomerulosclerosis.
Journal: Journal of the American Society of Nephrology : JASN
Published: August 16, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026